Influence of alginate on type II collagen fibrillogenesis

Development of chondrocyte-seeded electrosprayed nanoparticles for repair of articular cartilage defects in rabbits

Due to limited self-healing capacity in cartilages, there is a rising demand for an innovative therapy that promotes chondrocyte proliferation while maintaining its biofunctionality for transplantation. Chondrocyte transplantation has received notable attention; however, the tendencies of cell de-differentiation and de-activation of biofunctionality have been major hurdles in its development, delaying this therapy from reaching the clinic. We believe it is due to the non-stimulative environment in the injured cartilage, which is unable to provide sustainable physical and biological supports to the newly grafted chondrocytes. Therefore, we evaluated whether providing an appropriate matrix to the transplanted chondrocytes could manipulate cell fate and recovery outcomes. Here, we proposed the development of electrosprayed nanoparticles composed of cartilage specific proteins, namely collagen type II and hyaluronic acid, for implantation with pre-seeded chondrocytes into articular cartilage defects. The fabricated nanoparticles were pre-cultured with chondrocytes before implantation into injured articular cartilage. The study revealed a significant potential for nanoparticles to support pre-seeded chondrocytes in cartilage repair, serving as a protein delivery system while improving the survival and biofunctionality of transplanted chondrocytes for prolonged period of time.

Incorporation of aggrecan in interpenetrating network hydrogels to improve cellular performance for cartilage tissue engineering

Interpenetrating network (IPN) hydrogels were recently introduced to the cartilage tissue engineering literature, with the approach of encapsulating cells in thermally gelling agarose that is then soaked in a poly(ethylene glycol) diacrylate (PEGDA) solution, which is then photopolymerized. These IPNs possess significantly enhanced mechanical performance desirable for cartilage regeneration, potentially allowing patients to return to weight-bearing activities quickly after surgical implantation. In an effort to improve cell viability and performance, inspiration was drawn from previous studies that have elicited positive chondrogenic responses to aggrecan, the proteoglycan largely responsible for the compressive stiffness of cartilage. Aggrecan was incorporated into the IPNs in conservative concentrations (40 μg/mL), and its effect was contrasted with the incorporation of chondroitin sulfate (CS), the primary glycosaminoglycan associated with aggrecan. Aggrecan was incorporated by physical entrapment within agarose and methacrylated CS was incorporated by copolymerization with PEGDA. The IPNs incorporating aggrecan or CS exhibited over 50% viability with encapsulated chondrocytes after 6 weeks. Both aggrecan and CS improved cell viability by 15.6% and 20%, respectively, relative to pure IPNs at 6 weeks culture time. In summary, we have introduced the novel approach of including a raw material from cartilage, namely aggrecan, to serve as a bioactive signal to cells encapsulated in IPN hydrogels for cartilage tissue engineering, which led to improved performance of encapsulated chondrocytes.

Why Mechanical Properties of Collagen Scaffolds Should Be Tested in a Pseudo-Physiological Environment?

Collagen gels constitute an adequate scaffold for supporting the adhesion, proliferation and tissue regeneration of vascular cells inside a bioreactor. However, their mechanical properties should be enhanced not only for their manipulation but also to resist the mechanical constraints applied in the bioreactor. Actually, assessing the mechanical properties of a hydrogel requires many precautions since they are very sensitive to the environmental conditions (temperature, ionic strength, aqueous environment, etc). Whereas mechanical properties are usually measured directly in the air, the aim of this work was to evaluate the effects of a pseudo-physiological environment (PPE) on the mechanical properties of collagen gels. Furthermore, reinforcement was also tested using UV treatments (λ = 254 nm, 20 J/cm2), known to induce crosslinking. Irradiated samples were more resistant to enzymatic degradation and swelling tests showed that the crosslink density was increased by a factor of 30. This increase was thereafter correlated to the mechanical properties. Results showed that the UV-treated samples were stiffer and more brittle than the non-treated ones when tested in air. However, a 20% decrease and 40% increase were respectively measured on the linear modulus and strain at rupture when the gels were tested in the PPE. In the perspective of vascular tissue regeneration, these results show that the mechanical properties of a hydrogel should be performed in PPE in order to take into account the plasticization phenomenon that will occur in a bioreactor.

Modulation of collagen II fiber formation in 3-D porous scaffold environments

Collagen II, a major extracellular matrix component in cartilaginous tissues, undergoes fibrillogenesis under physiological conditions. The present study explored collagen II fiber formation in solution and in two- (coverslip) and three-dimensional (scaffold) environments under different incubation conditions. These conditions include variations in adsorption buffers, the presence of 1-ethyl-3-(3-dimenthylaminopropyl) carbodiimide/N-hydroxysuccinimide crosslinker and the nature of the material surfaces. We extend our observations of collagen II fiber formation in two dimensions to develop an approach for the formation of a fibrillar collagen II network throughout surface-modified polylactide-co-glycolide porous scaffolds. Morphologically, the collagen II network is similar to that present in native articular cartilage. Biological validation of the resultant optimized functional scaffold, using rat bone marrow-derived mesenchymal stem cells, shows appreciable cell infiltration throughout the scaffold with enhanced cell spreading at 24h post-seeding. This economic and versatile approach is thus believed to have significant potential in cartilage tissue engineering applications.

Strategies for articular cartilage lesion repair and functional restoration

Injury of articular cartilage due to trauma or pathological conditions is the major cause of disability worldwide, especially in North America. The increasing number of patients suffering from joint-related conditions leads to a concomitant increase in the economic burden. In this review article, we focus on strategies to repair and replace knee joint cartilage, since knee-associated disabilities are more prevalent than any other joint. Because of inadequacies associated with widely used approaches, the orthopedic community has an increasing tendency to develop biological strategies, which include transplantation of autologous (i.e., mosaicplasty) or allogeneic osteochondral grafts, autologous chondrocytes (autologous chondrocyte transplantation), or tissue-engineered cartilage substitutes. Tissue-engineered cartilage constructs represent a highly promising treatment option for knee injury as they mimic the biomechanical environment of the native cartilage and have superior integration capabilities. Currently, a wide range of tissue-engineering-based strategies are established and investigated clinically as an alternative to the routinely used techniques (i.e., knee replacement and autologous chondrocyte transplantation). Tissue-engineering-based strategies include implantation of autologous chondrocytes in combination with collagen I, collagen I/III (matrix-induced autologous chondrocyte implantation), HYAFF 11 (Hyalograft C), and fibrin glue (Tissucol) or implantation of minced cartilage in combination with copolymers of polyglycolic acid along with polycaprolactone (cartilage autograft implantation system), and fibrin glue (DeNovo NT graft). Tissue-engineered cartilage replacements show better clinical outcomes in the short term, and with advances that have been made in orthopedics they can be introduced arthroscopically in a minimally invasive fashion. Thus, the future is bright for this innovative approach to restore function.

Surface coupling of long-chain hyaluronan to the fibrils of reconstituted type II collagen

The aim of this study was to fabricate type II collagen fibrils with surface modified by long-chain hyaluronic acid. Monomeric type II collagen was isolated from bovine articular cartilage and reconstituted into collagen fibrils followed by a reaction with EDC (1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide)-activated long-chain hyaluronic acid. The existence of the hyaluronan molecules on the fibrillar surface was confirmed by the specific bindings of gold nanoparticles labeled with wheat germ agglutinin. The topographic pattern of type II collagen fibrils revealed by AFM scanning changed significantly after the surface coupling of hyaluronic acid. Beneath the hyaluronan, the characteristic D-bandings of the reconstituted collagen fibrils remained intact as shown by the results of TEM observation. The collagen fibrils became more resistant to collagenase digestion after surface coupling of hyaluronic acid as compared with that without hyaluronic acid immobilization. In addition, human mesenchymal stem cells encapsulated and cultured within the matrix of HA-collagen fibrils have a higher proliferation rate than cells grown within the unmodified type II collagen fibrils. The newly synthesized material of HA-collagen II fibrils has a great potential for use in constructing scaffold for tissue repair.

Preparation of nano-sized particles from collagen II by a high-voltage electrostatic field system

The pilot study describes a novel method for preparing nano-sized particles from collagen II using a high-voltage electrostatic field system. Observations from transmission electron microscopy showed that, in one of the cases, the nano-sized collagen II particles exhibited good sphericity, and the particles were in the range of 23.3+/-1.7 nm in diameter at the experimental setting of 3 kV cm(-1), for a 3 h treatment period and at 25 degrees C (with a collagen concentration of 0.2 mg ml(-1)). When the treatment temperature increased to 30 degrees C, the collagen II began to lose the tendency to form individually separated spherically shaped nano-particles. Moreover, a fibrous structure of collagen II was formed instead of a nano-particle shape at the temperature of 37 degrees C. This result is probably contributed to by an entropy-driven process that is termed fibrillogenesis, a larger force causing the collagen molecules to self-assemble and then form collagen fibrils. It is interesting to note that this is practically the first attempt to produce nano-particles directly from collagen II solution under the treatment of a high-voltage electrostatic field, together with a set of working parameters for the collagen concentration and low-temperature setting.